drugset / Trial / NCT05196295

To Evaluate the Safety of Treating Rheumatologic and Metabolic Patients With Molecular Hydrogen Supplement.

NCT05196295

Phase 1 Unknown 30 enrolled HoHo Biotech
NaSingle-groupOpen-labelSupportive care

Summary

The latest international research shows that supplementation of hydrogen molecules as an aid, adjuvant, can speed up the course of the disease. The purpose of this study is to determine the safety and possible efficacy of hydrogen supplements in different dose exposures for a clinical study in rheumatologic and metabolic patients. Patients will receive a different dosage of hydrogen capsules with their conventional treatment for a month. Investigators will test for any changes in haematologic, urine analysis and health status during and following the exposure period.

Timeline

Start
2022-01-11
Primary completion
2022-07-30
Completion
2022-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrogen Unknown Oral